Innovent Biologics Is A Prominent Biopharmaceutical Company Founded In 2011 And Based In Suzhouchinathe Company Specializes In The Development And Commercialization Of Innovative Medicinesfocusing On Providing Affordable Biologics For Various Diseasesincluding Cancerautoimmune Disorderscardiovascular And Metabolic Diseasesand Eye Conditions Innovent Biologics Is Engaged In The Discoverydevelopmentmanufacturingand Commercialization Of Biopharmaceuticalsit Operates A Modern Manufacturing Facility In Suzhou That Adheres To International Quality Standardsthe Company Also Has A Research Presence In The San Francisco Bay Areawhere It Conducts Studies On Disease Mechanisms And Technology Developmentinnovent Has Successfully Launched 15 Products In The Chinese Marketincluding Tyvytsintilimabfor Malignancies And Byvasdaa Biosimilar Of Bevacizumab With A Strong Pipeline Of Investigational Drugsinnovent Has Multiple Assets In Various Stages Of Clinical Trials And Partnerships With Over 30 Global Healthcare Companiesin 2022The Company Reported A Revenue Of Approximately Rmb 4 45 Billionreflecting Significant Growth And A Solid Net Profit Margin
No conferences found for this company.
| Company Name | Innovent Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
